Vivos Inc (RDGL) Stock Price, Quote & News

cycc Mar. 21 at 5:30 PM

$RDGL could rdgl hit.7?

2 · Reply

Doccjc62 Mar. 20 at 5:33 PM

$RDGL Almost a million shares traded today . RDGL heating up—good volume today as traders gear up for key catalysts. FDA IDE submission targeted for end of Q1 (any day now) or April, backed by strong progress and IsoPet safety data. In India, DCGI clearance anticipated later this quarter for expanded human RadioGel therapy. Looking forward to next week for some possible news .

1 · Reply

GRIG330 Mar. 20 at 4:59 AM

$RDGL lolling good lately… coming close to the resubmission

0 · Reply

Doccjc62 Mar. 19 at 4:18 PM

$RDGL Bids are building,,,, Looks like this one is ready to go...

0 · Reply

Doccjc62 Mar. 18 at 1:57 AM

$RDGL RDGL picking up steam as we hit the back half of March. FDA IDE submission for RadioGel human trials still on deck for end of Q1 (any day now) or early April. India DCGI clearance for expanded use could drop this quarter too. Production centers gearing up for Q2 ramp. This one feels like it's ready to run.

2 · Reply

Techallure Mar. 17 at 8:15 PM

$RDGL something about to break upward

3 · Reply

BullIsBest Mar. 17 at 6:24 PM

$RDGL Why did I buy so much of this stock? So little volume, hard to buy and sell. Should be an interesting 45 days.

0 · Reply

Fireballmillionaire Mar. 17 at 2:19 PM

$RDGL

0 · Reply

Chapdaddy14 Mar. 17 at 1:57 AM

$RDGL hopefully we will put patients first.

0 · Reply

bud63 Mar. 16 at 6:34 PM

$RDGL just a hair width being up another $3000

1 · Reply

UWB67 Mar. 16 at 9:33 AM

$RDGL Mid-MARCH 2026! [Vivos] has plans to submit the IDE [US] by the end of the first quarter [MARCH 2026] or in APRIL [2026]." - 10 Feb '26 PR. Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., to Support IDE Submission for RadioGel. - 27 Oct '25 Vivos PR. We [Vivos] continue to work toward anticipated DCGI [India] regulatory clearance later this quarter [MARCH 2026]. - 3 Feb '26 PR. Initial sales [of PrecisionGel] have been completed to a MAJOR university [?!] and a LARGE pharmaceutical company [?!] for evaluation. - 6 Nov '25 PR Starting in Q1 2026, the division [IsoPet] will implement profitability-focused initiatives. - 6 Nov '25 PR A clinical publication [for successfully treated equine ocular squamous cell carcinoma] is in development with Dr Ben Buchanan. - 6 Nov '25 PR [Vivos] anticipates that one of these facilities [two (US based and India based) new production sites] could be operational by the end of 2026. - 17 Feb '26 PR GO VIVOS GO!! 👏🤞

0 · Reply

Doccjc62 Mar. 16 at 2:40 AM

$RDGL Quiet accumulation in full swing at these depressed levels (~$0.08) while the FUD posts are exploding lately... That’s the classic sign we’re getting close to liftoff! The bashers always come out right before the real move. Major catalysts stacking RIGHT NOW: FDA IDE submission for RadioGel human trials — expected end of this month (Q1) or April (significant progress already announced) DCGI clearance in India for expanded human use — anticipated this quarter New U.S. + India production sites ramping (in-house manufacturing kicking off H1/Q2 2026) IsoPet veterinary exploding toward real revenue/profitability in 2026 Fresh U.S. patent + PRECISIONGEL trademark just locked in Smart money is loading quietly before the fireworks. FUD means we’re close.

1 · Reply

Doccjc62 Mar. 16 at 2:18 AM

$RDGL 6591 bling is 1hunglo on Ihub,,,, Wondewr what happened to him.. He used to be a supporter of the stock and now he's posting nonstop FUD. Probably sold too soon. Here are a few of his gems that he posted,,,, 1hunglo Re: None Saturday, June 25, 2022 4:54:23 PM Post# 147884 of 197427 Useless Debates, Wait ...Speculate,Rinse,Repeat....Myself as many here, have been a Long and a believer for years now in this ticker and its potential medical benefits. That is why I seldomly post, what would be the point?. We all know without a doubt that Vivos tech WORKS amazingly well and All bio plays TAKE MORE TIME..ANY OPINION posted in this chatroom or any others will never expedite the process or affect the pps. Lets keep it real and not self delude ourselves.So sit back and Enjoy the Ride. Not complicated. GLTY.

2 · Reply

6591Bling Mar. 16 at 1:32 AM

$RDGL pumper_stumper Re: doccjc post# 164238 Friday, March 13, 2026 4:46:36 PM Post# of 197427 This one might be your best, and that's a high bar! IDE APPROVAL is all that matters Dr Korenko is making sure the FDA gets what they want throughout the whole process to increase the likelihood of an approval . It’s like an open book final exam with the teacher walking you through every question. So then, despite the "open book test" with the FDA holding your geriatric CEO's hand, 2.5 years later, still no approval right? They walked him through it and he still failed? Let me guess, there is now nothing wrong with that failure, even given the "open book exam", right? You have a new excuse, right? Was this a sticky too? lol Given this embarrassment, you then have the nerve to pretty much say the same thing again, this year, with now a new reason, and have it a sticky? This is not due diligence, it's typical OTC wishing and dreaming!

1 · Reply

Doccjc62 Mar. 16 at 12:17 AM

$RDGL RDGL week ahead (March 15–21, 2026): Tight Q1 window closing—watch for potential announcements on: - FDA IDE submission for RadioGel® human trials: Targeted by end of March (or early April per Feb 10 update)—could drop any day now if on track. - DCGI clearance in India: Anticipated later this quarter for expanded human therapy phase—possible news or progress update incoming. -Ongoing momentum from manufacturing diversification (U.S./India sites ramping toward 2026 ops) and IsoPet® veterinary use could also spark mentions. Key catalysts still live—any filing or clearance PR could move it fast.

1 · Reply

UWB67 Mar. 15 at 11:51 PM

$RDGL Mid-MARCH 2026! [Vivos] has plans to submit the IDE [US] by the end of the first quarter [MARCH 2026] or in APRIL [2026]." - 10 Feb '26 PR. Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., to Support IDE Submission for RadioGel. - 27 Oct '25 Vivos PR. We [Vivos] continue to work toward anticipated DCGI [India] regulatory clearance later this quarter [MARCH 2026]. - 3 Feb '26 PR. Initial sales [of PrecisionGel] have been completed to a MAJOR university [?!] and a LARGE pharmaceutical company [?!] for evaluation. - 6 Nov '25 PR Starting in Q1 2026, the division [IsoPet] will implement profitability-focused initiatives. - 6 Nov '25 PR A clinical publication [for successfully treated equine ocular squamous cell carcinoma] is in development with Dr Ben Buchanan. - 6 Nov '25 PR [Vivos] anticipates that one of these facilities [two (US based and India based) new production sites] could be operational by the end of 2026. - 17 Feb '26 PR GO VIVOS GO!! 👏🤞

0 · Reply

6591Bling Mar. 15 at 11:36 PM

$RDGL RDGL Founded in 1994 by Radiogel scammer James Katzaroff...was a close business associate of Mike Korenko current CEO that began this scam stock over 30 years ago. One headline read in March 19, 2019 — “Former radiogel scammer James Katzaroff Terminated From SMI Capital Markets, Named In FINRA Investigation.” Katzaroff partnered and formulated the product with Korenko then handed the” business” to MK as he exited this company from a looming federal investigation. Stockholders left with continued failures of this scam ticker with always zero revenue and no FDA progress since inception for over 30 years as shareholders experience current FDA IDE REJECTIONS. The most recent rejection last year 2025 with one complete FDA denial before as MK ludicrously insist on dictating safety and efficacy testing terms to the regulatory board of the FDA and they continually reject his junk science with perpetual failures.

1 · Reply

Aerovestorman Mar. 15 at 1:08 PM

$RDGL It’s not difficult to spot a real trader with bearish analysis, and a Basher trying to undermine a company. You decide which one you’re seeing below 🙄🤪 Let’s all reflect on the web of corruption within the FDA & Big Pharma-Land, just for a moment, and how would that look?

1 · Reply

UWB67 Mar. 15 at 9:40 AM

$RDGL Mid-MARCH 2026! [Vivos] has plans to submit the IDE [US] by the end of the first quarter [MARCH 2026] or in APRIL [2026]." - 10 Feb '26 PR. Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., to Support IDE Submission for RadioGel. - 27 Oct '25 Vivos PR. We [Vivos] continue to work toward anticipated DCGI [India] regulatory clearance later this quarter [MARCH 2026]. - 3 Feb '26 PR. Initial sales [of PrecisionGel] have been completed to a MAJOR university [?!] and a LARGE pharmaceutical company [?!] for evaluation. - 6 Nov '25 PR Starting in Q1 2026, the division [IsoPet] will implement profitability-focused initiatives. - 6 Nov '25 PR A clinical publication [for successfully treated equine ocular squamous cell carcinoma] is in development with Dr Ben Buchanan. - 6 Nov '25 PR [Vivos] anticipates that one of these facilities [two (US based and India based) new production sites] could be operational by the end of 2026. - 17 Feb '26 PR GO VIVOS GO!

0 · Reply

6591Bling Mar. 15 at 4:13 AM

$RDGL Countless meetings with FDA and we already know at each and every turn MK either completely ignored FDA suggestions or failed to deliver the data FDA needs to consider Radiogel for human trials. WTF happened with that second set of rabbits? Radiogel leaked all over the place and MK buried the results. Instead, he gave FDA a bogus "study" with subclinical doses claiming proof of safe containment. But again, we already know FDA rejected that nonsense. Then he ran off to India and did same thing, but again, Indian health authorities shut down that nonsense. RDGL a perpetual SCAM that has been rejected again. Keep selling those worthless shares NO GO. LOL. No Go Korenko will never allow grounded common sense or business acumen in dealing with the FDA, simply because he possesses none of these two elements in his personality. Instead, just a pompous, egotistical, senile old man 80+, that once again is spending the investors $ not his. I became totally disillusioned with him years ago.

2 · Reply

Lochlank Mar. 13 at 8:34 PM

$RDGL @6591Bling hey bro stock price keeps going up are you seeing this???

4 · Reply

Aerovestorman Mar. 13 at 10:15 AM

$RDGL What a JOKER! Becoming a member in S/T just to troll one little company. No posts in anything else! This dude is a typical worm. 🥴🤪😵‍💫🙄

1 · Reply

Market Cap	41.00M
Revenue (ttm)	30,000.00
Net Income (ttm)	-2.91M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-9,700.00%
Debt to Equity Ratio	0.00

Volume	1,194,600
Avg Vol	552,548
Day's Range	N/A - N/A
Shares Out	455.54M
Stochastic %K	76%
Beta	-0.64
Analysts	Strong Buy
Price Target	N/A

Vivos Inc (RDGL)

Company Profile